0001209191-23-027374.txt : 20230504
0001209191-23-027374.hdr.sgml : 20230504
20230504165148
ACCESSION NUMBER: 0001209191-23-027374
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230502
FILED AS OF DATE: 20230504
DATE AS OF CHANGE: 20230504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanna Bastiano
CENTRAL INDEX KEY: 0001829069
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 23889674
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001829069
Sanna Bastiano
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Cell & Genetic Therapies
1
Common Stock
2023-05-02
4
S
0
1411
350.32
D
38302
D
Common Stock
2023-05-02
4
S
0
42
351.65
D
38260
D
Common Stock
2023-05-02
4
S
0
169
353.24
D
38091
D
Common Stock
2023-05-03
4
S
0
2053
350.44
D
36038
D
Common Stock
2023-05-03
4
S
0
728
351.60
D
35310
D
Transaction made pursuant to Mr. Sanna's company approved trading plan under Rule 10b5-1, which was entered into on 08/10/2022.
Mr. Sanna undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $350.32 (range $350.00 to $350.92).
Open market sales reported on this line occurred at a weighted average price of $351.65 (range $351.48 to $351.80).
Open market sales reported on this line occurred at a weighted average price of $353.24 (range $353.21 to $353.49).
Open market sales reported on this line occurred at a weighted average price of $350.44 (range $350.00 to $350.94).
Open market sales reported on this line occurred at a weighted average price of $351.60 (range $351.01 to $352.00).
/s/ Christiana Stevenson, Attorney-in-Fact
2023-05-04